Organic Process Research & Development
Communication
eluted with additional 50 mL of DCM (fraction 1, “f1”), and
then eluted with 100 mL of DCM/Acetone 95:5 (fraction 2,
“f2”) and 100 mL of DCM/Acetone 90:10 (fraction 3, “f3”).
The solvent of f2 was evaporated under reduced pressure and
product 2 as a white solid (281 mg, 0.60 mmol, 61% for
0.98 mmol scale; 1.46 g, 3.09 mmol, 63% for 4.90 mmol scale).
IR (film): 2958 cm−1 (w, C−H Ar) 2113 cm−1 (s, N3), 1749
1
cm−1 (s, CO), 1227 cm−1 (s, C−O ester). H NMR (400
1
was analyzed by H NMR to assess reaction outcome, and/or
MHz, CDCl3) δ 7.64−7.57 (m, 3H), 7.36−7.27 (m, 3H), 6.00
(d, J = 5.4 Hz, 1H, H-1), 5.47 (d, J = 2.5 Hz, 1H, H-4), 5.11
(dd, J = 10.8, 3.2 Hz, 1H, H-3), 4.67 (t, J = 6.4 Hz, 1H, H-5),
4.26 (dd, J = 10.8, 5.4 Hz, 1H, H-2), 4.05 (qd, J = 11.4, 6.6 Hz,
2H, H-6,6′), 2.15 (s, 3H, OC(O)CH3), 2.07 (s, 3H,
OC(O)CH3), 1.98 (s, 3H, OC(O)CH3). 13C NMR (101
MHz, CDCl3) δ 170.5, 170.1, 169.7 (3 × OC(O)CH3), 134.9,
129.3, 128.3, 127.7, 84.3 (C-1), 71.3 (C-3), 69.1 (C-5), 67.3
(C-4), 61.7 (C-6), 58.9 (C-2), 20.79, 20.77, 20.76 (3 ×
OC(O)CH3). HRMS (ESI) calcd for C18H21N3O7SeNa,
494.0437; found [M + Na]+, 494.0427.
crystallized from isopropanol to obtain target product 2.
Fractions f1 and f3 were kept until the absence of
carbohydrates (only required for screening and optimization
purposes) was confirmed by thin layer chromatography and/or
1
1H NMR. Quantifications were performed by H NMR of the
crude reaction mixture, using 1,2,4,5-tetramethylbenzene as an
internal standard (IS). Peak areas of IS δ 6.91 (s, 2H) and of
tion) were used for calculations.
Experimental Data for Monosaccharides 1−8. Galactal
1 was synthesized following previously reported procedures.22
Monosaccharides 2−8 were isolated from flow APS reactions.
Selenoglycoside 2 was isolated through recrystallization (see
below). Fractions enriched in monosaccharides 3−8 were
isolated exclusively for characterization purposes. Monosac-
charides 2−5 and 6−7 showed similar chromatographic
behavior, such that it was not possible to achieve full peak
resolution using preparative normal-phase HPLC. The
isopropanol filtrate of a 0.49 mmol flow APS synthesis was
purified using preparative HPLC purification, from which a
fraction enriched in 3 was isolated and repurified through
semipreparative HPLC to afford pure selenoglycoside 3.
Monosaccharides 4−8 were isolated from flow APS syntheses
on 0.49 mmol scale without filtration through silica prior to
silica gel chromatography (toluene/acetone 0−10% as eluent)
and subsequent preparative normal-phase HPLC chromatog-
raphy (hexanes/AcOEt 2−20% as eluent) allowed isolating
fractions enriched in 4−5, 6−7, and 8. For normal-phase (NP)
HPLC, YMC-Diol-300-NP columns were used (analytical: 150
mm × 4.60 mm I.D.; semipreparative: 150 mm × 10.0 mm
I.D.; preparative: 150 mm × 20.0 mm I.D.), with hexanes/
EtOAc as eluent (flow rates: 1.0, 5.0, and 15.0 mL/min for
analytical, semipreparative, and preparative chromatography,
respectively). The following gradient was used: (1) isocratic
2% EtOAc in hexanes (5 min); (2) linear gradient 2 to 20%
EtOAc in hexanes (30 min); (3) linear gradient to 100%
EtOAc (10 min).
Phenyl 3,4,6-Tri-O-acetyl-2-azido-2-deoxy-1-seleno-α-D-
talopyranoside (3). IR (film) 2950 cm−1 (w, C−H Ar),
2109 cm−1 (s, N3), 1750 cm−1 (s, CO), 1260 cm−1 (s, C−O
1
ester). H NMR (400 MHz, CDCl3) δ 7.59 (dd, J = 7.7, 1.8
Hz, 2H), 7.35−7.28 (m, 3H), 5.89 (s, 1H, H-1), 5.45−5.42
(m, 1H, H-4), 5.31 (t, J = 3.8 Hz, 1H, H-3), 4.70 (ddd, J = 7.3,
5.7, 1.7 Hz, 1H, H-5), 4.23−4.11 (m, 2H, H-6,6′), 4.08−4.06
(m, 1H, H-2), 2.20 (s, 3H, OC(O)CH3), 2.10 (s, 3H,
OC(O)CH3), 2.02 (s, 3H, OC(O)CH3). 13C NMR (101
MHz, CDCl3) δ 170.6 (OC(O)CH3), 170.5 (OC(O)CH3),
169.6 (OC(O)CH3), 134.34, 129.57, 128.63, 128.03, 83.1 (C-
1, JC−H = 174 Hz), 69.7 (C-5), 68.4 (C-3), 65.8 (C-4), 61.9
(C-6), 59.8 (C-2), 20.8, 20.7 (3 × OC(O)CH3). HRMS (ESI)
calcd for C18H21N3O7SeNa, 494.0437; found [M + Na]+,
494.0439.
3,4,6-Tri-O-acetyl-2-deoxy-2-selenophenyl-1-azido-α-D-
talopyranoside (4)14 and 3,4,6-Tri-O-acetyl-2-deoxy-2-
selenophenyl-1-azido-α-D-galactopyranoside (5). Mixture
of glycosides 4 and 5 (1.7:1). IR (film) 2965 cm−1 (w, C−H
Ar), 2113 cm−1 (s, N3), 1746 cm−1 (s, CO), 1214 cm−1 (s,
1
C−O ester). H NMR (400 MHz, CDCl3) δ 7.60−7.52 (m,
2H), 7.35−7.27 (m, 3H), 5.71 (d, J = 1.6 Hz, 0.6H, H-1 4),
5.67 (d, J = 4.0 Hz, 0.4H, H-1 5), 5.39−5.35 (m, 1H), 5.33−
5.30 (m, 0.6H, C−H 4), 5.23 (dd, J = 11.8, 3.1 Hz, 0.4H, C−H
5), 4.40 (ta, J = 6.5 Hz, 1H, H-5 4 and 5), 4.15 (m, 2H, H-6,6’
4 and 5), 3.57 (dd, J = 11.8, 4.0 Hz, 0.4H, H-2 5), 3.42 (ddd, J
= 5.1, 1.4, 0.8 Hz, 0.6H, H-2 4), 2.22 (s, 1.8H, C(O)CH3 4),
2.11 (s, 1.8H, C(O)CH3 4), 2.10 (s, 1.2H, C(O)CH3 5), 2.07
(s, 1.8H, C(O)CH3 4), 2.06 (s, C(O)CH3. 1.2H, 5), 1.89 (s,
1.2H, C(O)CH3 5). 13C NMR (101 MHz, CDCl3) δ 170.70
(C(O)CH3), 170.66 (C(O)CH3), 170.1 (C(O)CH3), 170.00
(C(O)CH3), 169.98 (C(O)CH3), 169.8 (C(O)CH3), 134.5,
134.4, 130.3, 129.7, 129.4, 128.9, 128.5, 128.2, 91.6 (C-1 4,
3,4,6-Tri-O-acetyl-α-D-galactal (1).31 1H NMR (400 MHz,
CDCl3) δ 6.47 (d, J = 6.1, 1H, H-1), 5.56 (s, 1H, H-3), 5.43 (s,
1H, H-4), 4.73 (d, J = 6.1, 1H, H-2), 4.38−4.28 (m, 1H),
4.28−4.16 (m, 2H), 2.13 (s, 3H), 2.09 (s, 3H), 2.03 (s, 3H).
13C NMR (101 MHz, CDCl3) δ 170.7, 170.4, 170.3
(OC(O)CH3), 145.5 (C-1), 98.9 (C-2), 72.9 (C-5), 64.0
(C-3), 63.8 (C-4), 62.0 (C-6), 20.98, 20.93, 20.8 (OC(O)
CH3).
Phenyl 3,4,6-Tri-O-acetyl-2-azido-2-deoxy-1-seleno-α-D-
galactopyranoside (2).12 Flow APS syntheses were performed
as described above, with stoichiometry and temperature as in
Table 1, entry 5. The following modifications on the reaction
setup were performed for the scale-up: The flow reactor was
built using 1.6 mm O.D. × 0.8 mm I.D. FEP tubing (reactor
volume: 12 mL). Sample loops were built with 3.2 mm O.D. ×
1.6 mm I.D. FEP or PFA tubing (Loop A: 6 mL and Loop B:
10 mL for 0.98 mmol scale; Loop A: 30 mL and Loop B: 34
mL for 4.9 mmol scale). Flow rates were set at fA = f B = 0.17
mL/min. Loop A was cooled to 0 °C for 4.9 mmol scale
reaction. Recrystallization from isopropanol afforded the
JC−H = 177 Hz), 90.9 (C-1 5, JC−H = 173 Hz), 69.8, 69.3, 69.0,
67.6, 66.7, 66.2, 62.0, 61.9, 46.0 (C-2 4), 43.4 (C-2 5), 21.07
(C(O)CH3), 21.03 (C(O)CH3), 20.86 (2 × C(O)CH3), 20.81
(C(O)CH3), 20.7 (C(O)CH3). HRMS (ESI) calcd for
C18H21N3O7SeNa, 494.0437; found [M + Na]+, 494.0438.
3,4,6-Tri-O-acetyl-2-azido-2-deoxy-1-azido-α,β-D-galacto-
pyranoside (6, 7).32 Mixture of glycosides 6 and 7 (7:1). IR
(film) 2113 cm−1 (s, N3), 1745 cm−1 (s, CO), 1224 cm−1 (s,
C−O ester). 1H NMR (400 MHz, CDCl3) δ 5.46 (dd, J = 3.3,
1.4 Hz, 0.87H, H-4 6), 5.43 (d, J = 3.4 Hz, 0.87H, H-1 6), 5.40
(dd, J = 11.0, 3.2 Hz, 0.87H, H-3 6), 5.35 (d, J = 3.3 Hz,
0.13H, H-4 7), 4.82 (dd, J = 10.9, 3.3 Hz, 0.13H, H-3 7), 4.71
(d, J = 7.9 Hz, 0.13H, H-1 7), 4.46 (t, J = 7.0 Hz, 0.87H, H-5
6), 4.16−4.03 (m, 2H, H-6,6′ 6, 7), 3.91 (td, J = 6.6, 1.2 Hz,
0.13H, H-5 7), 3.76 (dd, J = 11.0, 3.4 Hz, 0.87H, H-2 6), 3.67
E
Org. Process Res. Dev. XXXX, XXX, XXX−XXX